{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:17:01Z","timestamp":1770995821641,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1067\/mjd.2003.87","type":"journal-article","created":{"date-parts":[[2003,3,27]],"date-time":"2003-03-27T21:56:41Z","timestamp":1048802201000},"page":"548-552","source":"Crossref","is-referenced-by-count":69,"title":["Dermatologic side effects of thalidomide in patients with multiple myeloma"],"prefix":"10.1067","volume":"48","author":[{"given":"Virginia C.","family":"Hall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rokea A.","family":"El-Azhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Bouwhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.Vincent","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2003.87_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/ctrv.2000.0188","article-title":"A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma","volume":"26","author":"Rajkumar","year":"2000","journal-title":"Cancer Treat Rev"},{"issue":"Suppl","key":"10.1067\/mjd.2003.87_bib2","first-page":"9","article-title":"Thalidomide in hematologic and oncologic disease","volume":"14","author":"Rajkumar","year":"2000","journal-title":"Oncology (Huntingt)"},{"key":"10.1067\/mjd.2003.87_bib3","first-page":"168a","article-title":"Thalidomide plus dexamethasone (Thal\/Dex) and thalidomide alone (Thal) as first line therapy for newly diagnosed myeloma (MM)","volume":"96","author":"Rajkumar","year":"2000","journal-title":"Blood"},{"key":"10.1067\/mjd.2003.87_bib4","series-title":"Physicians' Desk Reference","first-page":"911","year":"2000"},{"issue":"Suppl 1","key":"10.1067\/mjd.2003.87_bib5","first-page":"604a","article-title":"Thalidomide alone or with dexamethasone for multiple myeloma","volume":"94","author":"Weber","year":"1999","journal-title":"Blood"},{"key":"10.1067\/mjd.2003.87_bib6","first-page":"385A","article-title":"A phase II trial of the anti-angiogenic agent, thalidomide, in patients with recurrent high-grade gliomas","volume":"16","author":"Fine","year":"1997","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1067\/mjd.2003.87_bib7","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1086\/513665","article-title":"Adverse reactions to thalidomide in patients infected with human immunodeficiency virus","volume":"24","author":"Haslett","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1067\/mjd.2003.87_bib8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0140-6736(91)91221-F","article-title":"Thalidomide hypersensitivity in AIDS","volume":"337","author":"Williams","year":"1991","journal-title":"Lancet"},{"key":"10.1067\/mjd.2003.87_bib9","first-page":"625","article-title":"Thalidomide and exfoliative dermatitis","volume":"56","author":"Salafia","year":"1988","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1067\/mjd.2003.87_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000246827","article-title":"Erythroderma due to thalidomide: report of two cases","volume":"189","author":"Bielsa","year":"1994","journal-title":"Dermatology"},{"key":"10.1067\/mjd.2003.87_bib11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1592\/phco.19.15.1177.30571","article-title":"Thalidomide-induced toxic epidermal necrolysis","volume":"19","author":"Horowitz","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1067\/mjd.2003.87_bib12","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1056\/NEJM200009283431315","article-title":"Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma","volume":"343","author":"Rajkumar","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2003.87_bib13","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","article-title":"Randomized comparison of thalidomide versus placebo in toxic epidermal necrolysis","volume":"352","author":"Wolkenstein","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/mjd.2003.87_bib14","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","article-title":"Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation","volume":"177","author":"Moreira","year":"1993","journal-title":"J Exp Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202614914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202614914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,24]],"date-time":"2019-03-24T09:54:53Z","timestamp":1553421293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962202614914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S0190962202614914"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2003.87","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}